Why the study?
It was unknown whether the non-invasive echocardiographic RVOT-VTI/PASP ratio correlates with invasive pulmonary arterial compliance, discriminates HFpEF-PH from PAH, and associates with functional capacity.
Does the echocardiographic RVOT-VTI/PASP ratio correlate with invasive pulmonary arterial compliance and discriminate between pulmonary hypertension subtypes in patients with PAH and HFpEF-PH?
Does the echocardiographic RVOT-VTI/PASP ratio correlate with invasive pulmonary arterial compliance and discriminate between pulmonary hypertension subtypes in patients with PAH and HFpEF-PH?
Answers are grounded in this paper and cite their sources.
Echocardiographic RVOT-VTI/PASP is a useful non-invasive metric that correlates with invasive pulmonary arterial compliance, distinguishes PH subtypes, and predicts functional capacity.
Pulmonary arterial compliance (PAC), invasively assessed by the ratio of stroke volume to pulmonary arterial (PA) pulse pressure, is a sensitive marker of right ventricular (RV)-PA coupling that differs across the spectrum of pulmonary hypertension (PH) and is predictive of outcomes. We assessed whether the echocardiographically derived ratio of RV outflow tract velocity time integral to PA systolic pressure (RVOT-VTI/PASP) (a) correlates with invasive PAC, (b) discriminates heart failure with preserved ejection-associated PH (HFpEF-PH) from pulmonary arterial hypertension (PAH), and (c) is associated with functional capacity. We performed a retrospective cohort study of patients with PAH (n = 70) and HFpEF-PH (n = 86), which was further dichotomized by diastolic pressure gradient (DPG) into isolated post-capillary PH (DPG < 7 mmHg; Ipc-PH, n = 54), and combined post- and pre-capillary PH (DPG ≥ 7 mm Hg; Cpc-PH, n = 32). Of the 156 patients, 146 had measurable RVOT-VTI or PASP and were included in further analysis. RVOT-VTI/PASP correlated with invasive PAC overall (ρ = 0.61, P < 0.001) and for the PAH (ρ = 0.38, P = 0.002) and HFpEF-PH (ρ = 0.63, P < 0.001) groups individually. RVOT-VTI/PASP differed significantly across the PH spectrum (PAH: 0.13 [0.010-0.25] vs. Cpc-PH: 0.20 [0.12-0.25] vs. Ipc-PH: 0.35 [0.22-0.44]; P < 0.001), distinguished HFpEF-PH from PAH (AUC = 0.72, 95% CI = 0.63-0.81) and Cpc-PH from Ipc-PH (AUC = 0.78, 95% CI = 0.68-0.88), and remained independently predictive of 6-min walk distance after multivariate analysis (standardized β-coefficient = 27.7, 95% CI = 9.2-46.3; P = 0.004). Echocardiographic RVOT-VTI/PASP is a novel non-invasive metric of PAC that differs across the spectrum of PH. It distinguishes the degree of pre-capillary disease within HFpEF-PH and is predictive of functional capacity.
No takes yet. Share an insight, caveat, or question.
Bhattacharya et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: